Accentia Biopharmaceuticals, based in Tampa, Florida, is a vertically-integrated specialty biopharmaceutical company formed by the Hopkins Capital Group and affiliates. The company has expertise in the areas of identification, development, regulatory approval, pricing, reimbursement, managed care contracting, manufacturing, and sales and marketing of biopharmaceuticals and medical devices
Scope of this report
Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Research and analysis highlights
The company currently markets pharmaceutical products through its Accentia Pharmaceuticals division. Its pharmaceutical product consulting business provides services to other pharmaceutical companies.
During 2002-2006, the company's total revenues increased at a CAGR of 74%, from $3 million to $22 million. Increased revenues from product sales were a major contributor to the company's total revenue growth during the historical period.
Accentia Biopharmaceuticals' revenues are expected to increase at a double-digit CAGR of 24% between 2006 and 2010, from $25 million to $59 million. This represents an absolute increase of +$34 million during the same period.
Key reasons to read this report
Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization
For more information kindly visit our website : http://www.bharatbook.com/detail.asp?id=76449
Discuss Add this link to... Bury
Scope of this report
Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Research and analysis highlights
The company currently markets pharmaceutical products through its Accentia Pharmaceuticals division. Its pharmaceutical product consulting business provides services to other pharmaceutical companies.
During 2002-2006, the company's total revenues increased at a CAGR of 74%, from $3 million to $22 million. Increased revenues from product sales were a major contributor to the company's total revenue growth during the historical period.
Accentia Biopharmaceuticals' revenues are expected to increase at a double-digit CAGR of 24% between 2006 and 2010, from $25 million to $59 million. This represents an absolute increase of +$34 million during the same period.
Key reasons to read this report
Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization
For more information kindly visit our website : http://www.bharatbook.com/detail.asp?id=76449
Discuss Add this link to... Bury
Comments